Based on 11 analysts giving stock ratings to Beta Bionics Inc in the past month.
In the current month, BBNX has received 4 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. BBNX average Analyst price target in the last month is 22.867.
Based on analysts' estimates, BBNX EPS is projected to reach -0.550 in FY2026Q3, following reported EPS of -0.525 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.53, while Beta Bionics IncBBNX's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.55.